Array ID Patient ID Age "patient survival (0=NED, 1=AWD, 2=DOD, 3=DOC)" survival months "event for Relapse Free Survival (0=NED, 1=Relapse)" Relapse Free Survival "p53 status (0=wild type, 1=mutation, ND= not determined)" "clinical ER (0=ER negative, 1=ER+ via immunohistochemical and/or DC-binding assay >9)" tumor cat=T node status=N met=M grade histology reference sample batch ID (four different idenpendently prepared batches were used) microarray batch - approximate # of genes on the microarray special comments svcc1114 stanford A 38 1 95 1 16 0 1 2 1 0 3 ductal CRA svcc-8k single tumor sample shac112 norway H2 32 1 40 1 15 1 0 1 0 0 2 ductal CRD shac-23k single tumor sample shac113 norway H3 31 2 43 1 29 1 1 3 1 0 2 ductal CRD shac-23k single tumor sample svn015 norway H4 38 0 60 0 60 0 1 2 0 0 2 ductal CRD svn-8k single tumor sample svl037 norway H5 28 2 17 1 9 1 0 2 0 0 3 ductal CRB svl-8k single tumor sample svn007 norway H6 ND DCIS CRD svn-8k single tumor sample svl012 norway 4 68 0 92 0 92 0 1 3 1 0 2 ductal CRA svl-8k before sample of chemotherapy pair svl006 norway 6 78 3 56 0 56 0 1 3 1 0 1 papillary CRA svl-8k before sample of chemotherapy pair svcc98 norway 7 66 1 89 1 39 1 1 3 2 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svl003 norway 8 47 2 22 1 22 0 0 3 1 0 1 ductal CRA svl-8k before sample of chemotherapy pair svo088 stanford 11 ND fibroadenoma CDB svo-8k fibroadenoma svcc78 norway 10 58 2 30 1 23 0 1 4 0 0 2 lobular CRA svcc-8k before sample of chemotherapy pair svcc122 norway 11 67 2 15 1 0 1 1 4 1 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc68 norway 19 74 2 20 1 0 1 1 4 1 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svcc53 norway 12 75 3 8 1 7 0 1 3 1 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc81 norway 14 82 2 12 1 11 0 1 4 2 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc106 norway 15 47 0 79 0 79 1 1 3 1 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svcc108 norway 16 74 0 78 0 78 0 1 4 2 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc88 norway 17 76 0 80 0 80 0 1 4 0 0 1 ductal CRA svcc-8k before sample of chemotherapy pair svcc134 norway 18 66 3 33 0 33 0 1 3 1 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svl015 norway 21 79 2 14 1 12 0 0 4 2 0 3 ductal CRA svl-8k before sample of chemotherapy pair svl027 norway 22 43 2 34 1 10 1 1 3 1 0 3 ductal CRA svl-8k before sample of chemotherapy pair svl016 norway 24 62 2 24 1 23 0 1 3 1 0 3 ductal CRA svl-8k before sample of chemotherapy pair svcc89 norway 26 72 2 43 1 9 1 1 3 0 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc111 norway 27 77 1 74 1 59 0 1 3 1 0 1 ductal CRA svcc-8k before sample of chemotherapy pair svcc1077 new york 1 46 1 100 0 100 0 1 0 2 ductal CRA svcc-8k tumor sample tested was a metastases in the ovary svl018 norway 29 46 0 74 0 74 0 1 3 0 0 2 lobular CRA svl-8k before sample of chemotherapy pair svcc132 new york 2 54 2 12 1 4 ND 0 3 1 0 3 ductal CRA svcc-8k single tumor sample svcc61 stanford 14 57 0 40 0 40 1 0 2 0 0 2 lobular CRA svcc-8k single tumor sample svcc137 stanford 16 77 2 14 1 14 1 1 3 1 0 3 ductal CRA svcc-8k single tumor sample svcc119 stanford 17 53 0 47 0 47 0 1 2 1 0 2 ductal CRA svcc-8k single tumor sample svl034 stanford 18 35 0 39 0 39 ND 1 3 1 0 3 ductal CRB svl-8k single tumor sample svcc96 stanford 2 44 2 5 1 4 1 0 3 1 0 3 ductal CRA svcc-8k single tumor sample svl107 stanford 20 ND fibroadenoma CRB svl-8k fibroadenoma shac110 norway 32 55 0 73 0 73 0 1 3 2 0 1 ductal CRD shac-23k before sample of chemotherapy pair svl104 norway 37 71 2 22 1 12 1 0 3 1 0 3 ductal CRB svl-8k after sample of chemotherapy pair svcc93 norway 39 85 0 67 0 67 1 1 3 0 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc107 norway 41 49 2 9 1 0 1 1 3 1 1 3 ductal CRA svcc-8k before sample of chemotherapy pair shac107 norway 43 45 0 69 0 69 0 1 3 1 0 1 ductal CRD shac-23k after sample of chemotherapy pair svcc76 norway 47 51 0 66 0 66 0 1 3 0 0 DCIS CRA svcc-8k before sample of chemotherapy pair svcc92 norway 48 54 2 7 1 4 0 0 3 0 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svcc99 stanford 23 34 0 25 0 25 1 0 1 0 0 3 ductal CRA svcc-8k single tumor sample svcc100 stanford 24 69 0 23 0 23 0 1 2 1 0 2 ductal CRA svcc-8k single tumor sample svl020 norway 51 53 0 60 0 60 1 1 3 2 0 3 ductal CRA svl-8k before sample of chemotherapy pair svcc131 norway 53 32 2 34 1 23 1 1 3 2 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svl103 norway 55 71 2 16 1 10 1 1 4 1 0 2 ductal CRB svl-8k before sample of chemotherapy pair svcc87 norway 56 64 0 61 0 61 0 1 3 1 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc51 norway 57 46 2 10 1 0 1 0 4 2 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svj104 stanford 31 48 0 16 0 16 0 1 1 1 0 2 ductal CRA svj-8k single tumor sample svcc118 stanford 35 52 1 19 1 16 1 1 3 2 0 3 ductal CRA svcc-8k single tumor sample svcc117 stanford 37 ND fibroadenoma CRA svcc-8k fibroadenoma svcc115 stanford 38 45 0 18 0 18 0 1 1 1 0 2 ductal CRA svcc-8k single tumor sample svl002 stanford 4 79 0 13 0 13 0 1 2 1 0 2 ductal CRB svl-8k "lymph node metastasis, primary tumor not tested" svl109 stanford 40 54 0 13 0 13 0 1 2 1 0 2 ductal CRB svl-8k single tumor sample svcc83 norway 61 58 0 57 0 57 0 1 3 0 0 3 lobular CRA svcc-8k before sample of chemotherapy pair svl033 norway 63 44 2 41 1 25 1 1 3 0 0 3 ductal CRB svl-8k before sample of chemotherapy pair svl029 norway 64 61 0 56 0 56 1 1 3 2 0 2 ductal CRA svl-8k before sample of chemotherapy pair shac093 norway 65 ND ductal CRD shac-23k "a second tumor from the other breast of patient 65, possibly an independent tumor from sample 406A-BE" svcc123 norway 65 66 2 23 1 0 0 0 4 2 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svl108 stanford 44 62 0 8 0 8 ND 0 1 0 0 3 ductal CRB svl-8k single tumor sample svl110 stanford 45 33 0 11 0 11 ND 0 2 1 0 2 ductal CRB svl-8k single tumor sample svl007 stanford 46 74 0 9 0 9 ND 0 1 1 0 3 ductal CRB svl-8k "lymph node metastasis, primary tumor not tested" svl022 stanford 48 52 0 4 0 4 ND 3 0 0 3 ductal CRB svl-8k single tumor sample shac091 norway 74 79 3 40 0 40 0 1 3 0 0 1 mucinous CRD shac-23k before sample of chemotherapy pair svl106 stanford 6 64 0 39 0 39 ND 1 2 0 0 3 ductal CRB svl-8k single tumor sample svl031 norway 80 58 2 11 1 9 1 0 3 2 0 2 ductal CRA svl-8k before sample of chemotherapy pair svl026 norway 81 52 2 13 1 8 0 1 3 2 0 3 ductal CRA svl-8k after sample of chemotherapy pair svl036 norway 83 79 1 45 1 0 0 1 4 0 1 2 ductal CRA svl-8k before sample of chemotherapy pair shac100 norway 85 79 0 39 0 39 0 1 4 1 0 2 ductal CRD shac-23k before sample of chemotherapy pair svl041 norway 90 64 0 36 0 36 0 1 4 2 0 2 ductal CRB svl-8k before sample of chemotherapy pair svl035 norway 96 40 0 30 0 30 0 1 3 0 0 1 lobular CRB svl-8k after sample of chemotherapy pair svl039 norway 98 57 0 32 0 32 1 1 3 1 0 2 pleomorph CRB svl-8k before sample of chemotherapy pair svcc104 norway 100 47 2 17 1 10 1 1 3 0 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svcc84 norway 101 73 1 33 1 20 1 1 3 2 0 2 ductal CRA svcc-8k before sample of chemotherapy pair svcc101 norway 102 65 0 29 0 29 0 1 4 2 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svcc120 norway 104 44 0 31 0 31 0 1 3 2 0 3 ductal CRA svcc-8k before sample of chemotherapy pair shac092 norway 95 76 1 33 1 0 1 1 4 2 0 3 ductal CRD shac-23k before sample of chemotherapy pair svcc130 new york 3 80 2 6 1 6 1 0 2 0 0 3 ductal CRA svcc-8k single tumor sample svcc105 norway 109 48 0 26 0 26 1 0 3 2 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svcc55 norway 111 55 0 30 0 30 0 1 3 0 0 3 ductal CRA svcc-8k before sample of chemotherapy pair svcc124 norway 112 37 0 22 0 22 0 1 3 1 0 1 ductal CRA svcc-8k before sample of chemotherapy pair svl024 clontech 3 normal breast CRB svl-8k pool of two tissue specimens and different than NB2 svcc70 clontech 1 normal breast CRA svcc-8k pool of 6 tissue specimens svcc127 clontech 2 normal breast CRA svcc-8k pool of two tissue specimens and different than NB3 svcc18 norway normal 1 normal breast CRA svcc-8k normal breast sample from a single individual